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Abstract 
Objectives 
To identify whether sleep disturbances are more prevalent in primary Sjögren’s syndrome 
(PSS) patients compared with the general population and to recognise which specific sleep 
symptoms are particularly problematic in this population. 
Methods 
Electronic searches of the literature were conducted in PubMed; Medline (OVID); Embase 
(OVID); PsychINFO (OVID) and Web of Science and the search strategy registered a priori. 
Titles and abstracts were reviewed by two authors independently against a set of pre-
specified inclusion/exclusion criteria, reference lists examined and a narrative synthesis of 
the included articles was conducted. 
Results 
Eight whole text papers containing nine separate studies met the inclusion criteria and were 
included in the narrative analysis. Few of these studies met all of the quality assessment 
criteria. The studies used a range of self-reported measures and objective measures 
including polysomnography. Mixed evidence was obtained for some of the individual sleep 
outcomes, but overall compared to controls PSS patients reported greater subjective sleep 
disturbances and daytime somnolence and demonstrated more night awakenings and pre-
existing obstructive sleep apnea.  
Conclusions 
A range of sleep disturbances are commonly reported in PSS patients. Further 
polysomnography studies are recommended to confirm the increased prevalence of night 
awakenings and obstructive sleep apnea in this patient group. PSS patients with excessive 
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daytime somnolence should be screened for comorbid sleep disorders and treated 
appropriately. Interventions targeted at sleep difficulties in PSS such as cognitive 
behavioural therapy for insomnia and nocturnal humidification devices have potential to 
improve quality of life this patient group and warrant further investigation. 
Key words 
Sjögren’s syndrome, systematic review, sleep, quality of life, disability evaluation.  
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Introduction 
Primary Sjögren’s syndrome (PSS) is a systemic autoimmune disease characterised by sicca 
symptoms[1]. Extraglandular features are commonly seen in PSS patients including 
fatigue[2], orthostatic intolerance[3], pain[4], and depression[5]. These patients commonly 
experience impaired function[6] and poor health related quality of life[8]. Fatigue is seen in 
75% of patients with PSS[7], is strongly correlated with poor quality of life [8-10] and is 
associated with functional impairment[6]. Due to the prevalence and impact of fatigue, 
there has been much research into factors associated with this symptom including potential 
genetic associations[11], and anti-inflammatory mechanisms[12]. Sleep disturbances have 
also been reported in the PSS literature[13] and are associated with fatigue [2]. In the 
general population, impaired sleep is associated with adverse health outcomes including 
weight gain, depression, pain, impaired immune function, impaired functional performance, 
increased risk of early mortality and cognitive symptoms including increased errors and 
increased risk of accidents[14]. Current recommendations are that adults should regularly 
have between seven and nine hours sleep, consistently per night[14].  
 
Many sleep disturbances are potentially modifiable[15-18]. Therefore the successful 
identification and treatment of sleep problems may have a positive effect on symptoms 
such as pain, mood and fatigue, resulting in improvements in in physical and cognitive 
functioning and quality of life.  
A previous review of sleep disturbances in rheumatological diseases included PSS[19], but 
was published some time ago and the PSS section was predominantly based on one 
comparative study which used RA patients as controls. Therefore an up-to-date systematic 
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review of the PSS sleep literature, which includes normative data on healthy controls, is 
required.   
 
The aim of this review was to identify all the published literature on sleep difficulties in PSS 
in order to answer the following questions: 
 Are sleep difficulties more prevalent in PSS patients than in the general population? 
 Which sleep difficulties are more prevalent in PSS patients than in the general 
population? 
Methods 
A systematic review of the published literature on sleep and PSS was conducted. The 
protocol was published prospectively with PROSPERO (CRD42015024977)[20]. The 
methodological framework used was the Preferred Reporting Items for Systematic Reviews 
and Meta-analyses (PRISMA) statement[21]. 
Eligibility criteria 
Eligible studies were English language, primary research papers published in full. These 
included intervention, diagnostic, prognostic and aetiological studies with adult participants 
(>18 years) with a diagnosis of PSS. Case studies and review papers were excluded. Where 
papers report mixed populations, only studies which analysed the PSS population separately 
were included. Outcomes had to include sleep outcomes and other outcomes which have a 
relationship with sleep. In mixed population studies PSS data had to be reported separately 
for PSS patients. Data for PSS data had to be compared with a control population, which 
could be healthy controls or controls with other diseases. Therefore studies which did not 
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compare data from a PSS group with a non-PSS control group were excluded from this 
review. 
Search strategy 
Databases (PubMed; Medline (OVID); Embase (OVID); PsychINFO (OVID) and Web of 
Science) were searched from inception to September 2015 using a pre-specified search 
string (Supplementary Table 1). The references of all included studies were also searched. 
Two reviewers (KH, ZG) independently examined the titles and abstracts of all records 
identified and full papers were retrieved for all papers which met inclusion criteria. All full 
text articles were screened by two review authors independently (KH, KD) for inclusion.  
Data extraction and quality assessment 
Data were extracted by one author (KH) onto a piloted form. These were checked by a 
second author (KD). Risk of bias was assessed at study level separately by two authors (KH 
and KD) using the Joanna Briggs Institute Prevalence Critical Appraisal Tool[22] and specific 
notes for questions within to tool were agreed between the authors (KH, KD) to reduce 
ambiguity prior to making a decision for each criteria (Supplementary Table 2). 
Disagreements between reviewers were resolved through discussion. 
Summary measures 
Any sleep summary measure which compared a PSS cohort with a comparative group was 
extracted. These include difference in means and medians and odds ratios. Data were 
combined in a narrative synthesis due to the expected heterogeneity of the included 
studies. 
Results 
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Nine studies from eight publications were identified for inclusion in this narrative review[13, 
23-29] (Figure 1). A summary of the included studies are in Table 1. Sixteen studies did not 
meet the inclusion criteria. Excluded studies with reasons for exclusion can be seen in 
Supplementary Table 3. One excluded study was a small uncontrolled study (n=9) of a 
nocturnal humidification device, which reduced nocturnal sicca symptoms in the 
participants[30]. Another excluded study included the use of an artificial saliva water spray, 
compared to placebo, to improve nocturnal oral dryness symptoms and improvements were 
demonstrated in both placebo and intervention groups[31]. This review did not set out to 
investigate interventions for PSS sleep disturbances, but these findings are considered in the 
context of potential future interventions in the discussion. 
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Ninety-three records were screened. Most studies were excluded at the title stage as they 
were not relevant to the review or did not fit the inclusion criteria (Figure 1). 14 publications 
were examined in more detail before exclusion (Supplementary Table 1) and nine studies 
from eight publications were included in this narrative review[13, 23-29] (Table 1). 
Gudbjörnsson et al[23] included two studies in their paper and these are referred to as 
Gudbjornsson et al Study 1 (a comparative study of sleep symptoms in three populations) 
and Study 2 (a polysomnography study) in this review for clarity.   
---------------------------------- Insert Figure 1 around here ----------------------------------------- 
---------------------------------- Insert Table 1 around here ------------------------------------------ 
Assessment of bias 
---------------------------------- Insert Figure 2 around here ------------------------------------------ 
The risk of bias quality assessment findings of the included studies can be viewed in Figure 
2. Three studies included only female PSS participants[13, 24, 29] and were consequently 
deemed as not being representative of the target population. Two studies (Gudbjörnsson et 
al Study 1 and Study 2)[23] used the Copenhagen Classification Criteria[32] to identify their 
subjects. These criteria were not validated or accepted universally[33], therefore these 
studies were also scored as not being representative of the target population. The 
remaining studies[13, 24-29] used either the European Community criteria[34] or the 
American European Consensus Group criteria[33]. 
Several studies did not fully specify how their participants were recruited (including 
Gudbjörnsson et al Study 1 and Study 2)[13, 23, 24, 28] and uncertainty remained for this 
item for these studies. The sample size was small (<40) for a number of studies (including 
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Gudbjörnsson et al Study 2)[13, 23, 24, 27, 28] and these studies were scored as being at 
high risk of bias for this question. 
Overall, three studies were deemed to be of high risk of bias (including Gudbjörnsson et al 
Study 2)[13, 23, 24], four at medium risk of bias (including Gudbjörnsson et al Study 1)[23, 
27-29] and two at low risk of bias[25, 26]. 
Prevalence of specific sleep difficulties in PSS  
The main sleep outcomes can be viewed in Table 2. 
---------------------------------- Insert Table 2 around here ------------------------------------------ 
Perceived sleep disturbance, (measured by sleep diary or patient reported sleep 
questionnaires) was reported in four studies (including Gudbjörnsson Study 1)[13, 23, 26, 
28]. Odds ratios were calculated from the data provided by one study[26]. PSS patients 
scored significantly worse than healthy controls for this outcome. It was unclear whether 
overall there is a higher prevalence of sleep disturbance in PSS patients compared with 
other disease groups (osteoarthritis (OA), rheumatoid arthritis (RA), systemic lupus 
erythrematosus (SLE)) as there were inconsistent findings between the studies.  
Time spent in bed was assessed in two studies with conflicting findings. One study 
objectively assessed this outcome with polysomnography (Gudbjörnsson Study 2,[23]), and 
the other measured time in bed subjectively with a patient reported sleep questionnaire[25] 
However the study which reported no difference for this outcome between PSS patients and 
healthy controls (Gudbjörnsson Study 2)[23] had very small numbers and took the 
measurements in a laboratory. The polysomnography study protocol and environment may 
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have influenced how long a participant remained in bed. Therefore it is not clear whether 
PSS patients do spend longer in bed compared with other populations.   
We identified five separate studies that examined total sleep duration including 
Gudbjörnsson Studies 1 and 2[13, 23, 24, 27]. Three small studies[13, 24, 27] compared a 
total of 53 PSS patients with RA patients (n=25)[13] or healthy controls (total n=26)[24, 27]. 
They found no significant differences between the groups in terms of total sleep time. 
However Gudbjörnsson et al (Study 1)[23] compared 40 people with PSS with 42 people 
with RA and 60 healthy controls. They identified that people with PSS reported significantly 
less sleep than the comparators as measured by sleep diaries (between 40 min to 1hour 45 
min less) and in their smaller polysomnography study (Study 2) they identified that PSS 
patients experienced between 1 hour 18 min to 2 hours less sleep than healthy controls.  
Three studies examined the proportions of time spent in each of the stages of sleep 
between PSS patients and controls (including Gudbjörnsson et al Study 2[23, 24, 27]. Two 
found that PSS patients spent more time in Stage 1 sleep than controls (Gudbjörnsson et al 
Study 2)[23, 24]. However Usmani et al[27] found no such difference. None of the studies 
found between group differences for other stages of sleep. 
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Sleep onset latency (time taken to fall asleep) was not significantly different between PSS 
patients, RA patients and healthy controls using self-reported methods in one study 
(Gudbjörnsson Study 1)[23], although the authors had not made a direct comparison 
between the PSS and control groups. However two studies (including Gudbjörnsson Study 
2)[23, 27] involving objective testing of this outcome (polysomnography) studies did find 
sleep onset latency to be greater in PSS patients (mean of 20 to 22 minutes) compared with 
controls (mean of 13.8[27], range 1.5 to 13.6 minutes[23]). 
Sleep efficiency (percentage of time spent in bed asleep) was identified as reduced in 
people with PSS in two studies (including Gudbjörnsson Study 2)[13, 23] both of which used 
objective measures. In a third study[24] with very low numbers, the sleep efficiency was 
very poor for both groups. However this could be due to the nasal mask that participants 
wore and the regular negative pressure pulses used to measure airway collapsibility, which 
may have interfered with their sleep. Therefore the environment was not ideal to examine 
sleep efficiency in this study. 
All studies which examined the number of night awakenings found that these were 
increased in PSS patients (Gudbjörnsson Study 2 and Theander et al)[23, 25] (see Table 2). 
That said, the polysomnography studies that report an arousal index (number of times sleep 
is interrupted) found no difference between PSS patients and comparison groups[24, 27].  
Factors associated with disturbed sleep 
A number of studies examined specific reasons for waking in the night.  
Theander et al[25] noted that 13% of their PSS group reported sicca symptoms which 
disturbed their sleep, compared with none of their controls. 
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Hilditch et al[24] found that nocturnal oral dryness did not differ significantly between PSS 
patients and controls which is surprising, but due to their very low numbers, could be a type 
II error. The same authors found that saliva surface tension showed no difference between 
the groups in the early morning, but was significantly higher in the PSS group in the late 
evening.  
Nocturnal pain and disturbed sleep was more common in PSS compared with controls and 
RA patients (Gudbjörnsson Study 1 and Theander et al)[23, 25]. Gudbjörnsson and 
colleagues (Study 1)[23] reported that 54% of their PSS group experienced nocturnal pain 
compared with 37% of their RA group (p<0.01) and 0% of their healthy control group 
(p<0.0001). Theander et al[25] found that nocturnal pain which disturbed sleep was present 
in 19% of their PSS group, which was greater than the 9% of those in the control group -
although this difference was not significant (p=0.07).  
There was conflicting evidence from two studies for nocturia disturbing sleep in PSS 
patients. Walker et al[29] investigated in nocturia and found no difference between PSS 
patients and an OA population for the occurrence of this symptom (OR 0.93, p=0.85). 
Conversely, Theander et al[25] found that 53% of their PSS participants experienced 
nocturia which disturbed sleep was present in 53% of their PSS participants, in comparison 
to 26% of their healthy controls (p=0.001).  
Autonomic Symptoms 
Nocturnal autonomic symptoms were only investigated by Gudbjörnsson et al (Study 1)[23], 
which found 20% of the PSS participants in this study reported experiencing nocturnal 
sweating, which was greater than their RA comparison group (12%, NS) and their healthy 
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controls (2%, p<0.01). Palpitations at night were reported in 5% of their PSS group and these 
were not present in either their RA or healthy control groups. 
Presence of co-morbid sleep disorders 
In Theander et al’s study[25], 2 of their 72 PSS cohort self-reported a diagnosis of narcolepsy 
compared with none of their controls, but this was not reported as an outcome in any of the 
other included studies.  
Using polysomnography, one study noted the occurrence of obstructive apneas and 
hypopneas were double in their PSS group compared with healthy controls[27]. In this 
study, continuous positive airway pressure (CPAP) treatment was offered to  eight out of 
twenty eight PSS study participants who were identified as having severe sleep apnea (with 
an apnea-hypnea index score ≥40). Five participants accepted the treatment and significant 
improvements were demonstrated both in their Epworth Sleepiness Scale (ESS) scores and 
fatigue scores at 2-6 months after commencing CPAP treatment.  
However another study[24] investigated the upper airway collapsibility and found no 
difference in both the upper airway collapsibility index and a range of respiratory variables 
between their PSS and control groups but this could be due to the study being 
underpowered.  
Daytime somnolence 
Four studies identified increased daytime sleepiness in patients with PSS compared to 
healthy controls. Gudbjörnson et al (Study 1)[23] found their PSS patients were sleepy in the 
daytime five-times more frequently than RA controls and almost three-times more 
frequently than healthy controls. Theander et al (2010), Usmani et al (2012) and Walker et 
Systematic review of sleep disturbances in primary Sjögren’s syndrome 
14 
 
al (2003) reported that Epworth Sleepiness Scale scores were significantly higher in PSS 
patients than in controls[25, 27, 29].  
Discussion 
Findings of the review 
We have found that subjective and objective sleep disturbances are more common in PSS 
patients. Further research is needed to examine the differences between PSS patients and 
other disease groups.  
There were inconclusive findings regarding whether PSS patients spend more time in bed 
than comparative groups, however, if they do spend longer in bed it is likely that this is due 
to the sleep disturbances and night awakenings they experience. Further studies are needed 
to confirm whether PSS patients have a short sleep duration compared with other groups, 
due to the conflicting findings in this review. However PSS patients do seem to experience 
more frequent nocturnal awakenings than other groups. Despite this finding, the arousal 
index scores were not found to be greater for PSS patients in the studies that examined this 
outcome. One reason could be due to low numbers of participants in these studies. 
However an alternative suggestion is that the PSS patients awaken more frequently during 
these arousals, due to their symptoms such as dryness, pain and autonomic symptoms. A 
further possibility is that PSS patients may demonstrate high frequency EEG throughout the 
night which may influence their perception of sleep and wakefulness. Further investigations 
would be required to test this.  
Sicca symptoms did disturb sleep in one study[25] and potential interventions to reduce 
these symptoms, and thus improve sleep will be discussed shortly. Pain is another symptom 
which is more common in PSS patients during the night. Segal and colleagues have observed 
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that sleep quality reduced as pain increases[4]. If pain is reduced, sleep quality might 
therefore improve. 
There were conflicting findings regarding the symptom of nocturia in PSS patients. However, 
PSS patients regularly drink to ease the symptoms of their dryness. Needing the toilet during 
the night could be a natural consequence of this.  
Although autonomic symptoms were only reported in one included study, there is a greater 
prevalence of these symptoms in PSS patients[3] and it is logical that these symptoms, 
which can include palpitations, dizziness and sweats, may interfere with sleep.   
There does seem to be an increased prevalence of obstructive sleep apnea in PSS patients, 
although further studies are needed to reproduce this finding. The Epworth Sleepiness Scale 
can be used as a screening to identify patients who are at risk of obstructive sleep apnea[35] 
and these patients should be referred for further investigations.  
This review has demonstrated that daytime sleepiness is a problem in PSS patients. Daytime 
sleepiness correlates with reduced quality of life[10], fatigue[25, 29], autonomic 
dysfunction[3] and functional impairment[6]. Furthermore, patients with who are 
functionally impaired have significantly greater Epworth Sleepiness Scale scores than those 
who experience no functional disability[6]. 
Potential interventions for sleep disturbances in PSS 
Interventions which address the perception of poor sleep without the necessity for 
objective verification, include addressing unhelpful beliefs surrounding sleep, addressing 
sleep efficiency and prescribing time in bed. These are all components of a Cognitive 
Behavioural Therapy for Insomnia (CBT-I) intervention[36]. CBT-I is considered as a first line 
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treatment for insomnia associated with a medical condition[37] and is an effective 
intervention in other long term conditions[38], therefore could be beneficial in PSS. Time in 
bed and sleep efficiency are both addressed in the sleep restriction component of a CBT-I 
intervention and this may be a useful way of addressing longer spells spent in bed awake in 
this patient group, and lead to improved sleep. Further studies of CBT-I and various modes 
of delivering this intervention are therefore warranted in this patient group. 
Nocturnal humidification and artificial saliva sprays may ease nocturnal sicca symptoms and 
decrease sleep disturbances in PSS patients and are unlikely to contribute towards bladder 
disturbances during the night. Although a humidification device did seem to be a promising 
intervention in an excluded study[30], further appropriately powered studies comparing  
nocturnal humidification devices in PSS with controls are required to demonstrate efficacy. 
For autonomic symptoms which interfere with sleep, appropriate interventions addressing 
these symptoms, such as water bolus treatment during the day[39] may also help to 
improve sleep, particularly if these symptoms are regularly experienced during the night. 
Further research is required to demonstrate the efficacy of interventions for dysautonomia 
such as blood pressure dysregulation in PSS on sleep outcomes. 
Further considerations 
A more detailed sleep assessment, including polysomnography, may be beneficial for this 
group when considering the level of sleep apnea reported in this population. Moreover, 
polysomnography will afford a closer examination of other objectively verifiable sleep 
disorders which may influence sleep (e.g. narcolepsy, periodic limb movement disorder, 
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restless legs syndrome and hypersomnolence disorders). If severe sleep apnea is identified 
in PSS patients, CPAP treatment should be offered[40].  
Pain is another symptom which can interrupt sleep. PSS patients who experience pain which 
is interfering with their sleep should be offered appropriate pain management 
interventions[4]. CBT-I is efficacious at improving sleep duration, continuity and perceived 
quality in chronic pain patients with co-morbid insomnia and CBT-I with an additional pain 
component is feasible[38]. A pain adjunct to a CBT-I intervention may therefore improve 
sleep in PSS patients with chronic pain. Interventions targeting sleep disturbances in PSS 
may improve daytime sleepiness and fatigue which could result with increased functional 
capacity and quality of life. 
There are some limitations to this review.  Firstly, although we did not specifically 
investigate potential causes of sleep disturbances, we have uncovered several potential 
contributing factors from within the included studies. However there may be further 
potential complications in PSS which might play a role in sleep disturbance, such as 
gastroesophageal reflux[41]. Further work needs to be done to determine the causes of 
sleep disturbances in this patient group. Secondly, although we did not set out to 
investigate specific interventions for sleep disturbances, we have identified some 
uncontrolled studies of interventions for sleep in PSS. There may therefore be further 
studies of interventions for sleep disturbances in PSS uncovered by our search. However a 
recent systematic review of all non-pharmacological interventions for PSS did not identify 
any randomized controlled trials for sleep difficulties in this patient group[42]. Furthermore 
recent meta-analysis of twenty three studies determined that CBT-I was efficacious at 
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reducing sleep disturbances and improving sleep quality in patients with insomnia 
secondary to a comorbid condition[43].  
This review included a total of 350 PSS patients in nine separate studies. Only two studies 
(with 142 PSS patients) were deemed to be at low risk of bias. This highlights the paucity of 
high quality existing research into sleep disturbances in PSS patients. 
Conclusion 
From the included studies in this review, we found an increased prevalence of sleep 
disturbances in PSS patients compared with controls, including; daytime somnolence; 
subjective sleep disturbances including disturbance due to dryness symptoms, and 
increased occurrence of night awakenings. Sleep apnea may be more common, but further 
polysomnography studies are required to confirm this. 
Although we did not set out to investigate interventions, logic dictates that CBT-I for sleep 
disturbances and night awakenings and nocturnal humidifiers for nocturnal sicca symptoms 
would be beneficial in this patient group. However further studies are required to confirm 
their effectiveness in PSS. Due to the variable quality of the included studies, the mix of 
outcomes assessed within these studies and the overall low numbers of patients included 
within them, we recommend further studies to add to the body of PSS sleep prevalence 
literature. Finally, in the presence of sleep difficulties in PSS patients, primary sleep 
disorders should be screened for and treated appropriately.   
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Key Messages 
 This is the first published review of sleep disturbances of primary SS. 
 Sleep disturbances are common in primary SS patients and should be identified 
and treated appropriately. 
 Future investigations of sleep interventions for primary SS are warranted. 
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Tables 
Table 1. Summary of included studies
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Author, year 
and country 
Study design Participants Sleep Outcomes 
 
Goodchild 
2010 
UK [13] 
Observational 
prospective study  
PSS: n=14, AECG diagnostic criteria for PSS[29], 100% 
female, mean age=58, mean disease duration (MDD)=13 
RA: n=25, 100% female, mean age=62, MDD=9 years 
Sleep diary 
Actigraphy 
 
Gudbjörnsson 
1993 
Sweden [23] 
Study 1 
Cross sectional 
sleep 
questionnaire  
Study 2 
Observational 
study. 
Polysomnography 
for 2 consecutive 
nights. 
Study 1: 
PSS: n=40, Copenhagen diagnostic criteria for PSS [32], 
95% female, mean age-53. 10 PSS patients also had PSG 
RA: n=42, ARA criteria for classical RA [44], 100% female, 
10 had symptoms of secondary Sjögren’s syndrome 
HC: n=60, 100% female, Age matched with the PSS 
participants 
Study 2: 
PSS: n=10, no demographic information provided.  
HC: n=30, Middle aged 
Study 1: 
Uppsala Sleep Inventory [45] 
Study 2: 
Polysomnography  
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Author, year 
and country 
Study design Participants Sleep Outcomes 
 
Hilditch 2008 
Australia [24] 
Observational 
study over a nights 
sleep  
PSS: n=11, AECG diagnostic criteria for PSS, 100% female, 
mean age=61, MDD not reported 
HC: n=8, All female, mean age=55.9, Age matched with 
patient group 
Electroencephalogram, 
electrooculogram, submental 
electromyogram. Respiratory 
(inspiratory flow, end-tidal CO2 and 
mask leak). Breathing effort. Upper 
airway collapsibility. Oral wetness and 
saliva surface tension 
Theander 
2010 
Sweden [25] 
Cross sectional 
survey  
PSS: n=77, AECG criteria for PSS, 90% female, median 
age=61, MDD=12 
HC: n=59, 90% female, Median age=55 
Epworth Sleepiness Scale [46], Restless 
Legs Syndrome questionnaire [47], Lund 
University Sleep Questionnaire [25], 
Profile of Fatigue, fatigue VAS 
Tishler 1997 
Israel [26] 
Cross sectional 
survey. 
PSS: n=65, AECG classification criteria for PSS, 92% female, 
Mean age =57.3, MDD=8.3 
Mini Sleep Questionnaire [26] 
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Author, year 
and country 
Study design Participants Sleep Outcomes 
 
 RA (Group A): n=67, 83% female, MDD=12.6 years 
RA with sicca symptoms (Group B): n=63, 70% female, 
MDD=15.1 years 
OA: n=31, 94% female, MDD=10.3 years 
Usmani 2012 
Australia [27] 
Observational 
study  
PSS: n=28, 100% female, AECG classification criteria for 
PSS, mean age=58.7, MDD not stated 
HC: n=18, 100% female, mean age=55.8 
Epworth Sleepiness Scale 
Polysomnography 
Apnea-Hypopnea Index [27] 
van Oers 2010 
Netherlands 
[28] 
Repeated 
measures study to 
compare variability 
of fatigue during 
the day  
PSS: n=29, 100% Female, AECG criteria for PSS, mean age 
53.3, MDD not stated 
SLE: n=23, 100% Female 
RA: n=19, 100% Female 
HC: N=52, 100% Female, Mean age 51 
15 Item Dutch questionnaire on sleep 
quality [48] 
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Author, year 
and country 
Study design Participants Sleep Outcomes 
 
Walker 2003 
Australia [29] 
A study comparing 
differences in 
urinary symptoms 
and daytime 
sleepiness  
PSS: n=76, European Community criteria for PSS, 100% 
female, median age=58, MDD not stated 
OA: n=43, 100% female, median age=64 
Epworth Sleepiness Scale, FACIT-F [49], 
American Urological Symptom Index 
[50] 
Notes: AECG, American-European Consensus Group Criteria; ARA, American Rheumatism Association; HC, healthy controls; MDD, mean disease duration; OSA, Obstructive sleep apnea; RA, 
Rheumatoid arthritis; SLE, systemic lupus erythematosus; OA, Osteoarthritis; PSS, primary Sjögren’s syndrome; VAS, Visual analogue scale,  
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Table 2. Differences in specific sleep outcomes between PSS patients and controls 
 Study Results PSS 
Perceived sleep 
disturbance 
Goodchild 2010 
[13] 
PSS vs RA not significantly different for quality of sleep or feeling of refreshment ND 
Gudbjörnsson 1993 
Study 1 [23] 
44% PSS not feeling rested after sleep vs 9.8% RA (p<0.001) and 15.3% HC (p<0.01) + 
Tishler 1997 [26] Moderate/severe sleep disturbance 75% PSS. Significantly greater than OA and RA (p<0.01) + 
van Oers 2010 [28] Significant differences sleep disturbance (p<0.001) between all groups (SLE, RA, HC, PSS). PSS 
highest median (6/15), HC lowest (2.3/15).  
+ 
Time spent in 
bed 
Gudbjörnsson 1993 
Study 2 [23] 
PSS mean time in bed (500 min, range 444-532) similar to HC, range 419-514 ND 
Theander 2010 
[25] 
PSS 45 min more in bed vs HC (8.24 vs. 7.72 hours; p=0.048)  + 
Total sleep time Goodchild 2010 
[13] 
PSS mean 7h asleep, similar to RA  ND 
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Gudbjörnsson 1993 
Study 1 [23] 
PSS mean of 5.2h asleep (SD=1.90), significantly less than RA (6.8h SD=1.30) P<0.05) & HC 
(7.2h SD=0.77, P<0.0001) 
+ 
Gudbjörnsson 1993 
Study 2 [23] 
PSS mean 358 min asleep (range 183-473) less thanHC range (396-466 min) + 
Hilditch 2008 [24]  No difference total sleep time PSS vs HC ND 
Usmani 2012 [27] No difference total sleep time  PSS vs HC ND 
Sleep onset 
latency 
Gudbjörnsson 1993 
Study 1 [23] 
Mean time to fall asleep greatest in PSS (30 min SD=52.49) vs RA (21 min SD=19.44) and HC 
(19 min SD=6.97) difference not significant.  
ND 
Gudbjörnsson 1993 
Study 2 [23] 
PSS mean 20 min to fall asleep (range 3-65), greater than HC range (1.5 to 13.6 min) + 
Usmani 2012 [27] PSS mean 22.8 min to fall asleep (range 14-40) vs 13.8 for HC (range 6-22) (p=0.035) + 
Sleep efficiency Goodchild 2010 
[13] 
PSS 84% sleep efficiency significantly less than RA 89.4% (p<0.05) + 
Gudbjörnsson 1993 
Study 2 [23] 
PSS 70% mean sleep efficiency, well below control range (94%-100%) + 
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Hilditch 2008 [24] No difference PSS group  vs HC (combined mean 44% sleep efficiency) ND 
Number of 
night 
awakenings 
Gudbjörnsson 1993 
Study 1 [23] 
PSS woke mean 2.6 times, significantly more than RA (1.5) (p<0.0001) and HC(1.0) (p<0.05) + 
Gudbjörnsson 1993 
Study 2 [23] 
PSS woke mean 19 times (polysomnography) vs HC (range 1-7) + 
Theander 2010 
[25] 
PSS awakenings (mean 2.7 SD=0.17) higher than HC(mean 1.7 SD=0.18, p=0.001) + 
Arousal index Hilditch 2008 [24] Trend of higher mean nocturnal arousals in PSS vs HC (p<0.06) ND 
Usmani 2012 [27] No difference PSS vs HC (p=0.18) ND 
Ventilatory 
measurements 
& sleep apnea 
Hilditch 2008 [24] No difference PSS vs HC for upper airway collapsibility index and respiratory variables  ND 
Usmani 2012 [27] Twice frequency of apneas and hypoapneas in PSS vs HC (p=0.032) 
Sleep apnea 64% PSS vs 28% controls (p=0.03) 
+ 
Daytime 
somnolence 
Gudbjörnson 1993 
Study 1 [23] 
PSS significantly more daytime sleepiness vs HC  (p<0.001) or RA (p<0.0001). PSS significantly 
more daytime naps PSS 15.2% vs HC  0% (p<0.01) but not RA 21.4% 
+ 
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Theander 2010 
[25] 
PSS significantly worse daytime sleepiness (ESS; mean 9.5, SD=5.2) vs HC (mean 7, SD=4.0) 
(p=0.003)and significantly more excessive sleepiness (15.3%) vs HC (11.9%) (p=0.016) 
+ 
Usmani 2012 [27] PSS significantly worse for daytime sleepiness (ESS; mean 10.1, SD=5.82) vs HC (mean 6.5, 
SD=3.39) p=0.014 
+ 
Walker 2003 [29] PSS daytime sleepiness significantly worse vs OA (OR 2.50, p=0.01) + 
Notes: + Favours controls; ESS Epworth Sleepiness Scale; h hours; HC healthy controls; min minutes; ND No difference; OA osteoarthritis; PSS primary Sjogren’s syndrome; RA rheumatoid 
arthritis, SLE systemic lupus erythematosus. P values are reported when provided in the published studies. 
